Jump Financial’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-20,458
Closed -$527K 2198
2025
Q3
$527K Buy
+20,458
New +$502K 0.01% 1258
2024
Q4
Sell
-152,609
Closed -$2.3M 1913
2024
Q3
$2.3M Buy
152,609
+140,309
+1,141% +$2.4M 0.05% 466
2024
Q2
$352K Sell
12,300
-27,969
-69% -$796K 0.01% 1311
2024
Q1
$1.18M Buy
40,269
+969
+2% +$29.8K 0.03% 716
2023
Q4
$1.33M Sell
39,300
-19,573
-33% -$573K 0.04% 564
2023
Q3
$1.81M Buy
58,873
+47,173
+403% +$1.7M 0.07% 412
2023
Q2
$469K Buy
+11,700
New +$484K 0.02% 1061
2023
Q1
Sell
-35,382
Closed -$1.37M 1945
2022
Q4
$1.37M Buy
+35,382
New +$1.72M 0.07% 367
2022
Q1
Sell
-6,463
Closed -$389K 1817
2021
Q4
$389K Buy
+6,463
New +$356K 0.02% 772
2021
Q3
Sell
-24,685
Closed -$1.5M 1403
2021
Q2
$1.5M Buy
+24,685
New +$1.56M 0.14% 176

Other funds holding PCRX